Eric Schuur
FounderChief Executive Officer, Co-Founder at Hepatx
Palo Alto, California, United States
FoundedHepatx · YC
Find your path to Eric
963 people in our graph share verified history with Eric — schools, employers, funds. One of them is your warm intro.
.jpeg)
About
Eric Schuur is the Chief Executive Officer and co-founder of HepaTx Corporation, where he leads the development of cell therapies for liver disease. His background spans biopharma and medical devices, including work on Calydon's oncolytic virus, contributions to the Asthmatx clinical team that brought the Alair System to market, and consulting on diagnostic technologies from Genomic Health and Janssen Diagnostics. He has raised more than $4 million, authored over 30 peer-reviewed papers and posters, and is an inventor on seven patents.
Chief Executive Officer, Co-Founder at HepatxYC S18
Intro paths
Eric went through Y Combinator (Summer 2018) — any YC alum in your network can reach them through the YC community.
In turn, Eric can intro founders to Hepatx's investors below.
Experience
- HepaTx CorporationChief Executive Officer, Co-foundercurrent2015 — presentPalo Alto, California, United States
- BioIntel ConsultingConsultantcurrent2023 — presentBend, Oregon; Palo Alto, California
- ISCT, International Society for Cell & Gene TherapyGastrointestinal Committeecurrent2024 — present
- California Life Science-CIRMCell and Gene Therapy Working Groupcurrent2024 — present
- Advanced Regenerative Manufacturing InstituteStandards Working Groupcurrent2023 — present
- Advanced Regenerative Manufacturing InstituteLeadership Advisory Councilcurrent2024 — presentManchester, New Hampshire, United States
- StartX Med Labs Cooperative Inc.Directorcurrent2021 — presentPalo Alto, California, United States
- VMWA LLCPrincipal2009 — 2019Palo Alto, CA
- Asthmatx, Inc.Director of Clinical Affairs2005 — 2009
- GeneSource, Inc.Chief Executive Officer1998 — 2005
- Stanford UniversityVisiting Scholar2000 — 2003Palo Alto, CA
- Calydon, Inc.Director of Molecular Biology1994 — 1997
Skills & more
+8 more
BiotechnologyR&DClinical TrialsDrug DiscoveryPharmaceutical IndustryGenomicsFDAResearch and Development (R&D)From Eric's professional profile.
Frequently asked questions
- Who is Eric Schuur?
- Eric Schuur is the Chief Executive Officer and co-founder of HepaTx Corporation, where he leads the development of cell therapies for liver disease. His background spans biopharma and medical devices, including work on Calydon's oncolytic virus, contributions to the Asthmatx clinical team that brought the Alair System to market, and consulting on diagnostic technologies from Genomic Health and Janssen Diagnostics. He has raised more than $4 million, authored over 30 peer-reviewed papers and posters, and is an inventor on seven patents.
- Where does Eric Schuur work?
- Eric Schuur is Chief Executive Officer, Co-Founder of Hepatx.
- What companies did Eric Schuur found?
- Eric Schuur founded Hepatx.
- Where did Eric Schuur go to school?
- Eric Schuur studied at UCLA (PhD, Experimental Pathology); Y Combinator; StartX (Founder, S16).
Founder mafias
Y Combinator mafia10,230
Also came through, then founded or led a company.
+ 10,223 more
Stanford University mafia1,932
Also came through, then founded or led a company.
+ 1,925 more
UCLA mafia357
Also came through, then founded or led a company.
+ 350 more
StartX mafia86
Also came through, then founded or led a company.
+ 79 more
Same school
Also attended UCLA833
+ 827 more
Also attended Y Combinator2,000
+ 1,994 more
Shared employers
Also worked at ISCT, International Society for Cell & Gene Therapy3
Also worked at Asthmatx, Inc.1
Also worked at Stanford University1,044
+ 1,038 more